retatrutide clinical trial weight loss data ๐ may be redefining obesity treatment. New from TRIUMPH-1 showed: ๐ฅ ~28% average over 80 weeks ๐ฅ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic GLP-1 Medications for Weight Loss:
Description
Blood pressure reductions observed in clinical trials, averaging nearly 10 mm Hg systolic and 4 mm Hg diastolic, translate to meaningful cardiovascular risk reduction
Force customers to get their prescriptions through their contracted pharmacy instead of the lowest cost provider, as there is profit in mark ups
Some people find they have more mental bandwidth for exercise, relationships, and work once they're no longer dominated by hunger signals and food decisions
Key lessons: Continuity matters: Early discontinuation correlates with substantially lower weight loss and loss of blood sugar gains
